Latest Commercialisation News

Page 11 of 239
Lithium Universe’s CEO and chief technical officer will leave on 30 October, prompting a search for a new chief executive while the company advances its lithium refining and recycling plans. No interim CEO or successor has been announced.
Victor Sage
Victor Sage
23 Oct 2026
Gold Hydrogen has secured up to $2 million against its verified FY2026 R&D claim and can seek a further $4 million against FY2027 expenditure. The funding gives the explorer near-term support for well-testing analysis and commercialisation studies, but carries a 16.5% annual interest rate and security over its R&D claims.
Maxwell Dee
Maxwell Dee
23 Oct 2026
Proteomics International will take Promarker D and Promarker Eso nationwide through Healius from 26 October, extending its first commercial release beyond Western Australia and the Northern Territory. The tests will initially be offered privately at $495 and $997, while revenue remains too uncertain to forecast.
Victor Sage
Victor Sage
23 Oct 2026
BluGlass has expanded its customer-funded GaN laser programs with a A$1.4 million Uviquity contract and a new A$286,000 photonics collaboration. But its A$8 million facility is fully drawn, carries 16.5% interest and leaves reported funding coverage at 2.8 quarters.
Victor Sage
Victor Sage
23 Oct 2026
Argent BioPharma ended the September quarter with just A$11,000 in cash after A$734,000 of operating outflows, despite retaining A$7.4 million of unused convertible financing capacity. The company is simultaneously expanding its commercial portfolio through NLC antiviral rights and a CannEpil veterinary programme.
Victor Sage
Victor Sage
23 Oct 2026
Recce Pharmaceuticals has granted Arrotex exclusive rights to commercialise its investigational RECCE 327 topical gel in Australia and New Zealand. The agreement offers a potential profit-share stream, but no upfront payments, sales forecast or approval have been disclosed.
Ada Torres
Ada Torres
22 Oct 2026
Orthocell’s flagship Remplir nerve-repair product gained ground in the US and Thailand during the September quarter, even as total revenue slipped from the June period. The company reported A$39 million in available funds and said it does not currently expect to raise additional capital.
Ada Torres
Ada Torres
22 Oct 2026
Sierra Nevada Gold has started a 25,000-metre second-phase drilling campaign at its As Safra copper-gold project in Saudi Arabia, with the first assay results due in November. The company is directing capital and management attention to Saudi Arabia while exploring commercial options for its Nevada portfolio.
Maxwell Dee
Maxwell Dee
21 Oct 2026
CurveBeam AI has secured its strongest first-quarter HiRise sales result, gained China regulatory clearance and raised A$7.35 million to fund the next stage of commercialisation. The progress comes alongside lower customer receipts and a reported 4.3 quarters of cash runway.
Victor Sage
Victor Sage
21 Oct 2026
Iondrive received $3.765 million in grant cash during FY2026, including $3.691 million from the Australian Government’s Industry Growth Program. The company has deferred $1.671 million of that funding until further eligible pilot plant expenditure is incurred.
Victor Sage
Victor Sage
21 Oct 2026
Provaris Energy has accepted $914,500 in final Share Purchase Plan applications after delayed electronic transfers pushed demand 50% above its $600,000 target. The raise will fund hydrogen and LCO₂ development, while a proposed option package still requires shareholder approval.
Maxwell Dee
Maxwell Dee
21 Oct 2026
First Graphene reported unaudited first-quarter income of about A$201,000, up 21% year on year, as PureGRAPH moved into new cement, mining, composites and footwear applications. The commercial pipeline expanded, but A$915,000 of operating cash outflow left the company with A$1.831 million and an estimated two quarters of funding at the reported burn rate.
Victor Sage
Victor Sage
20 Oct 2026

Browse the archive

Full archive